Insulin and glucagon secretion in hepatic glycogenoses. 1979

S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino

Insulin and glucagon secretion was investigated in ten patients with hepatic glycogenosis, types I and III, in order to understand the relationship between hypoglycemia and pancreatic function. In all patients, both oral glucose tolerance and intravenous arginine infusion tests revealed hypoinsulinemia. Decreased urinary C-peptide levels with standard food intake also supported hypofunction of pancreatic beta cells. On the contrary, the normal secretion pattern of glucagon in both types indicated in the arginine loading test, intact alpha cells in the pancreas. Persistent hypoinsulinism, which is apparently an adaptation to hypoglycemia, could be an important cause of nutritional dwarfism in both types of glycogenosis. The usefulness of the measurement of urinary C-peptide, which evaluates the pancreatic function and provides management for normal body growth, is discussed.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
April 2014, Cell metabolism,
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
July 1978, The American journal of physiology,
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
November 1965, Lancet (London, England),
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
December 1986, Neuroscience letters,
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
June 1971, Lancet (London, England),
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
January 1988, Annales de gastroenterologie et d'hepatologie,
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
October 1971, Lancet (London, England),
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
April 1967, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
October 1971, Ugeskrift for laeger,
S Okada, and Y Seino, and H Kodama, and T Yutaka, and K Inui, and M Ishida, and H Yabuuchi, and Y Seino
June 1981, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Copied contents to your clipboard!